Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Researchers in China and South Korea have developed a rapid immunodot assay to detect aquaporin 4-targeting IgG autoantibodies in the serum of individuals with neuromyelitis optica spectrum disorder.
A new study indicates that although men and women are equally likely to experience cognitive impairment after acute ischaemic stroke, there are sex differences in particular cognitive domains. Whether these differences are directly linked to biological sex is uncertain, as many factors, including age and pre-stroke factors, could contribute to cognitive outcomes.
Two recent studies leverage the same French population-based disease registry to describe real-world medication prescription patterns, patient characteristics and treatment effectiveness in people with schizophrenia. These studies also identify disparities in the health care and outcomes of these individuals compared with those of the general population.
Here, the authors discuss evidence for the involvement of the cerebellum in Parkinson disease. They cover the anatomical connections between the cerebellum and basal ganglia and how functional and connectivity alterations observed in the cerebellum of people with the disease relate to specific clinical symptoms.
The term amyotrophic lateral sclerosis (ALS)–frontotemporal spectrum disorder encompasses a spectrum ranging from pure motor ALS to ALS with frontotemporal dementia. This Review focuses on the cognitive and behavioural impairments that are found in the mid-range of this spectrum.
Acquired neurocognitive impairment affects 30–50% of the 38 million people living with HIV worldwide. Here, the authors provide an overview of the proposed mechanisms of HIV-associated neurocognitive impairment and describe potential and emerging therapeutics and non-pharmacological interventions.
Understanding of the pathogenetic mechanisms underlying cerebral malaria remains incomplete despite intense scrutiny. Hadjilaou et al. discuss potential treatment strategies targeting pathogen replication and clearance, host–pathogen interactions at the cerebrovasculature or leveraging host innate and adaptive immunity.